Aaron Falcione - Organon Executive Officer
| OGN Stock | USD 18.55 0.13 0.71% |
Executive
Aaron Falcione is Executive Officer of Organon Co
| Age | 52 |
| Address | 30 Hudson Street, Jersey City, NJ, United States, 07302 |
| Phone | 551 430 6900 |
| Web | https://www.organon.com |
Organon Management Efficiency
The company has Return on Asset of 0.0722 % which means that on every $100 spent on assets, it made $0.0722 of profit. This is way below average. Organon's management efficiency ratios could be used to measure how well Organon manages its routine affairs as well as how well it operates its assets and liabilities. As of the 30th of April 2024, Return On Capital Employed is likely to grow to 0.28, while Return On Tangible Assets are likely to drop 0.14. At this time, Organon's Non Current Assets Total are very stable compared to the past year. As of the 30th of April 2024, Intangibles To Total Assets is likely to grow to 0.53, while Total Assets are likely to drop about 11.9 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Frank Mount | Chevron Corp | N/A | |
| David MD | Amgen Inc | 61 | |
| Michael Guptan | Walmart | N/A | |
| Arvind Sood | Amgen Inc | N/A | |
| Courtney McKeown | Air Lease | N/A | |
| Robert Binns | HP Inc | 46 | |
| Ryan McKenna | Air Lease | N/A | |
| Wayne Borduin | Chevron Corp | N/A | |
| Marie Myers | HP Inc | 56 | |
| Harvey Anderson | HP Inc | 49 | |
| Eric Hoogenkamp | Air Lease | N/A | |
| David Rozzion | HP Inc | N/A | |
| Matthew Busch | Amgen Inc | 50 | |
| Matthew Miner | Walmart | N/A | |
| Timothy Brown | HP Inc | 57 | |
| Sabrina CPA | Air Lease | N/A | |
| Allyson Park | Walmart | N/A | |
| Alan Russell | Amgen Inc | N/A | |
| Mike Zahigian | Amgen Inc | N/A | |
| Antonio Lucio | HP Inc | 65 | |
| Elisabeth Moreno | HP Inc | N/A | |
Management Performance
| Return On Asset | 0.0722 |
Organon Leadership Team
Elected by the shareholders, the Organon's board of directors comprises two types of representatives: Organon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Organon. The board's role is to monitor Organon's management team and ensure that shareholders' interests are well served. Organon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Organon's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matthew Walsh, Executive CFO | ||
| Susan ONeal, Chief Officer | ||
| Rebecca Edwards, Chief Officer | ||
| Rachel Stahler, Executive Officer | ||
| Susanne Fiedler, Executive Officer | ||
| Daniel Karp, Chief Officer | ||
| Aaron Falcione, Executive Officer | ||
| Geralyn Ritter, Sustainability Affairs | ||
| Kevin Ali, CEO Director | ||
| Meghan Rivera, US Director | ||
| Jennifer Halchak, Vice Relations | ||
| Joseph Morrissey, Executive Supply | ||
| Kirke Weaver, General VP | ||
| Vittorio Nisita, Executive Services | ||
| MD JD, Ex RD |
Organon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Organon a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.0722 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 12.98 B | ||||
| Shares Outstanding | 255.64 M | ||||
| Shares Owned By Insiders | 0.14 % | ||||
| Shares Owned By Institutions | 79.48 % | ||||
| Number Of Shares Shorted | 10.94 M | ||||
| Price To Earning | 4.20 X | ||||
| Price To Book | 1.84 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Organon information on this page should be used as a complementary analysis to other Organon's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Organon Stock analysis
When running Organon's price analysis, check to measure Organon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organon is operating at the current time. Most of Organon's value examination focuses on studying past and present price action to predict the probability of Organon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organon's price. Additionally, you may evaluate how the addition of Organon to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Organon's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.06 | Dividend Share 1.12 | Earnings Share 3.99 | Revenue Per Share 24.538 | Quarterly Revenue Growth 0.076 |
The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.